(Circulation. 2002;105:2766.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
From the Center for Molecular Imaging Research (C.-H.T., U.M., V.N., R.W.) and the Cardiovascular Research Center and Cardiology Division (J.C., R.G., M.C.F., P.L.H.), Massachusetts General Hospital, Harvard Medical School, Boston.
Correspondence to Ralph Weissleder, MD, PhD, MGH-Center For Molecular Imaging Research, Building 149, 13th Street, Room 5406, Charlestown, MA 02129-2060. E-mail weissleder{at}helix.mgh.harvard.edu
Background Atherosclerotic plaque rupture, the most important cause of acute cardiovascular incidents, has been strongly associated with vascular inflammation. On the basis of the hypothesis that the inflammatory response and proteolysis lead to plaque rupture, we have examined the role of cathepsin B as a model proteolytic enzyme.
Methods and Results Using western-type dietfed apoE and apoE/endothelial NO synthase double knockout mice as models of atherosclerosis, we show (1) that cathepsin B is upregulated in atherosclerotic lesions characterized by high degrees of inflammation compared with normal aorta or silent lesions,(2) that intravenously injectable novel cathepsin B imaging beacons are highly activated within active atherosclerotic lesions and colocalize with cathepsin B immunoreactivity, and(3) that cathepsin B activity in atherosclerotic lesions can be imaged in whole animals by using a novel near-infrared tomographic imaging system.
Conclusions These studies indicate that cathepsin B, and potentially other proteases, may serve as a biomarker for vulnerable plaques when probed with beacons. The tomographic in vivo imaging method as well as catheter-based optical sensing methods could be readily adapted to screening and potentially to the molecular profiling of a number of proteases in vulnerable plaque in vivo.
Key Words: atherosclerosis enzymes cathepsin B imaging
This article has been cited by other articles:
![]() |
H. F. Langer, R. Haubner, B. J. Pichler, and M. Gawaz Radionuclide imaging a molecular key to the atherosclerotic plaque. J. Am. Coll. Cardiol., July 1, 2008; 52(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wu, C. Sharan, H. Yang, J. S. Goodwin, L. Zhou, G. A. Grabowski, H. Du, and Z. Guo Apolipoprotein E-deficient lipoproteins induce foam cell formation by downregulation of lysosomal hydrolases in macrophages J. Lipid Res., December 1, 2007; 48(12): 2571 - 2578. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Upadhyay, R. A. Sheth, R. Weissleder, and U. Mahmood Quantitative Real-time Catheter-based Fluorescence Molecular Imaging in Mice Radiology, November 1, 2007; 245(2): 523 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. M. Lutgens, K. B. J. M. Cleutjens, M. J. A. P. Daemen, and S. Heeneman Cathepsin cysteine proteases in cardiovascular disease FASEB J, October 1, 2007; 21(12): 3029 - 3041. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Jaffer, P. Libby, and R. Weissleder Molecular Imaging of Cardiovascular Disease Circulation, August 28, 2007; 116(9): 1052 - 1061. [Full Text] [PDF] |
||||
![]() |
F. A. Jaffer, D.-E. Kim, L. Quinti, C.-H. Tung, E. Aikawa, A. N. Pande, R. H. Kohler, G.-P. Shi, P. Libby, and R. Weissleder Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor Circulation, May 1, 2007; 115(17): 2292 - 2298. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Sosnovik, M. Nahrendorf, N. Deliolanis, M. Novikov, E. Aikawa, L. Josephson, A. Rosenzweig, R. Weissleder, and V. Ntziachristos Fluorescence Tomography and Magnetic Resonance Imaging of Myocardial Macrophage Infiltration in Infarcted Myocardium In Vivo Circulation, March 20, 2007; 115(11): 1384 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Saloner, G. Acevedo-Bolton, M. Wintermark, and J. H. Rapp MRI of Geometric and Compositional Features of Vulnerable Carotid Plaque Stroke, February 1, 2007; 38(2): 637 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Aikawa, M. Nahrendorf, D. Sosnovik, V. M. Lok, F. A. Jaffer, M. Aikawa, and R. Weissleder Multimodality Molecular Imaging Identifies Proteolytic and Osteogenic Activities in Early Aortic Valve Disease Circulation, January 23, 2007; 115(3): 377 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Papaspyridonos, A. Smith, K. G. Burnand, P. Taylor, S. Padayachee, K. E. Suckling, C. H. James, D. R. Greaves, and L. Patel Novel Candidate Genes in Unstable Areas of Human Atherosclerotic Plaques Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1837 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-o Deguchi, M. Aikawa, C.-H. Tung, E. Aikawa, D.-E. Kim, V. Ntziachristos, R. Weissleder, and P. Libby Inflammation in Atherosclerosis: Visualizing Matrix Metalloproteinase Action in Macrophages In Vivo Circulation, July 4, 2006; 114(1): 55 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nasu, E. Tsuchikane, O. Katoh, D. G. Vince, R. Virmani, J.-F. Surmely, A. Murata, Y. Takeda, T. Ito, M. Ehara, et al. Accuracy of In Vivo Coronary Plaque Morphology Assessment: A Validation Study of In Vivo Virtual Histology Compared With In Vitro Histopathology J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2405 - 2412. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Vasan Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations Circulation, May 16, 2006; 113(19): 2335 - 2362. [Full Text] [PDF] |
||||
![]() |
A. Zaheer, M. Murshed, A. M. De Grand, T. G. Morgan, G. Karsenty, and J. V. Frangioni Optical Imaging of Hydroxyapatite in the Calcified Vasculature of Transgenic Animals Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1132 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Jaffer, P. Libby, and R. Weissleder Molecular and Cellular Imaging of Atherosclerosis: Emerging Applications J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1328 - 1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Dollery and P. Libby Atherosclerosis and proteinase activation Cardiovasc Res, February 15, 2006; 69(3): 625 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lutgens, S.P.M. Lutgens, B.C.G. Faber, S. Heeneman, M.M.J. Gijbels, M.P.J. de Winther, P. Frederik, I. van der Made, A. Daugherty, A.M. Sijbers, et al. Disruption of the Cathepsin K Gene Reduces Atherosclerosis Progression and Induces Plaque Fibrosis but Accelerates Macrophage Foam Cell Formation Circulation, January 3, 2006; 113(1): 98 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Ferrara, D. Weiss, P. H. Carnell, R. P. Vito, D. Vega, X. Gao, S. Nie, and W. R. Taylor Quantitative 3D fluorescence technique for the analysis of en face preparations of arterial walls using quantum dot nanocrystals and two-photon excitation laser scanning microscopy Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R114 - R123. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nighoghossian, L. Derex, and P. Douek The Vulnerable Carotid Artery Plaque: Current Imaging Methods and New Perspectives Stroke, December 1, 2005; 36(12): 2764 - 2772. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Bonow Molecular Beacons Illuminate Subcellular Events Circulation, April 12, 2005; 111(14): 1730 - 1732. [Full Text] [PDF] |
||||
![]() |
J. Chen, C.-H. Tung, J. R. Allport, S. Chen, R. Weissleder, and P. L. Huang Near-Infrared Fluorescent Imaging of Matrix Metalloproteinase Activity After Myocardial Infarction Circulation, April 12, 2005; 111(14): 1800 - 1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Jaffer and R. Weissleder Molecular Imaging in the Clinical Arena JAMA, February 16, 2005; 293(7): 855 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Anderson Candidate-based proteomics in the search for biomarkers of cardiovascular disease J. Physiol., February 15, 2005; 563(1): 23 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Matter, P. K. Schuler, P. Alessi, P. Meier, R. Ricci, D. Zhang, C. Halin, P. Castellani, L. Zardi, C. K. Hofer, et al. Molecular Imaging of Atherosclerotic Plaques Using a Human Antibody Against the Extra-Domain B of Fibronectin Circ. Res., December 10, 2004; 95(12): 1225 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Moulton, B. R. Olsen, S. Sonn, N. Fukai, D. Zurakowski, and X. Zeng Loss of Collagen XVIII Enhances Neovascularization and Vascular Permeability in Atherosclerosis Circulation, September 7, 2004; 110(10): 1330 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, G. K. Sukhova, J.-S. Sun, W.-H. Xu, P. Libby, and G.-P. Shi Lysosomal Cysteine Proteases in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1359 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Galis Vulnerable Plaque: The Devil Is in the Details Circulation, July 20, 2004; 110(3): 244 - 246. [Full Text] [PDF] |
||||
![]() |
M. A. Funovics, R. Weissleder, and U. Mahmood Catheter-based in Vivo Imaging of Enzyme Activity and Gene Expression: Feasibility Study in Mice Radiology, June 1, 2004; 231(3): 659 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Morgan, K. Rerkasem, P. J. Gallagher, B. Zhang, G. E. Morris, P. C. Calder, R. F. Grimble, P. Eriksson, W. L. McPheat, C. P. Shearman, et al. Differences in Matrix Metalloproteinase-1 and Matrix Metalloproteinase-12 Transcript Levels Among Carotid Atherosclerotic Plaques With Different Histopathological Characteristics Stroke, June 1, 2004; 35(6): 1310 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shah, C.-H. Tung, K. Yang, R. Weissleder, and X. O. Breakefield Inducible Release of TRAIL Fusion Proteins from a Proapoptotic Form for Tumor Therapy Cancer Res., May 1, 2004; 64(9): 3236 - 3242. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Wickline Plaque characterization: surrogate markers or the real thing? J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1185 - 1187. [Full Text] [PDF] |
||||
![]() |
F. A. Jaffer and R. Weissleder Seeing Within: Molecular Imaging of the Cardiovascular System Circ. Res., March 5, 2004; 94(4): 433 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shah, C.-H. Tung, C.-H. Chang, E. Slootweg, T. O'Loughlin, X. O. Breakefield, and R. Weissleder In Vivo Imaging of HIV Protease Activity in Amplicon Vector-transduced Gliomas Cancer Res., January 1, 2004; 64(1): 273 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lutgens, R.-J. van Suylen, B. C. Faber, M. J. Gijbels, P. M. Eurlings, A.-P. Bijnens, K. B. Cleutjens, S. Heeneman, and M. J.A.P. Daemen Atherosclerotic Plaque Rupture: Local or Systemic Process? Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2123 - 2130. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. MacNeill, H. C. Lowe, M. Takano, V. Fuster, and I.-K. Jang Intravascular Modalities for Detection of Vulnerable Plaque: Current Status Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1333 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
NOS3-/- Mice Sci. Aging Knowl. Environ., July 23, 2003; 2003(29): tg6 - 6. [Full Text] |
||||
![]() |
F. J. Pashkow The prudent person's paradox J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1480 - 1481. [Full Text] [PDF] |
||||
![]() |
U. Mahmood and R. Weissleder Near-Infrared Optical Imaging of Proteases in Cancer Mol. Cancer Ther., May 1, 2003; 2(5): 489 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-R. Han, A. Momeni, K. Strach, P. Suriyaphol, D. Fenske, K. Paprotka, S. I. Hashimoto, M. Torzewski, S. Bhakdi, and M. Husmann Enzymatically Modified LDL Induces Cathepsin H in Human Monocytes: Potential Relevance in Early Atherogenesis Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 661 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oberhoff and K. R Karsch Who wants his plaque sealed? Eur. Heart J., March 2, 2003; 24(6): 494 - 495. [Full Text] [PDF] |
||||
![]() |
T. F. Massoud and S. S. Gambhir Molecular imaging in living subjects: seeing fundamental biological processes in a new light Genes & Dev., March 1, 2003; 17(5): 545 - 580. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |